Nitzan Rosenfeld receives Translational Research Award
Congratulations to Nitzan Rosenfeld, who has won the 2013 British Association for Cancer Research Translational Research Award.
The purpose of the award is to recognise and reward the achievements of an individual whose work has made significant contributions to translational (laboratory – clinic) cancer research.
The lab are working on developing effective methods to make use of circulating tumour DNA (ctDNA), which is found in blood and other body fluids and contains much useful information about a patient’s cancer. For example, by using genomic techniques to study ctDNA researchers can learn about the evolution of a patient’s tumour and how it is developing resistance to therapy. The advantage of using ctDNA to diagnose and monitor disease is that it can be collected relatively non-invasively, through a blood test rather than a tumour biopsy, and ease of sample collection means that you can take many more samples to follow the development and changes in a tumour.
Related News
See all news-
Imaging technique allows rapid assessment of ovarian cancer subtypes and their response to treatment
6th December 2024
An MRI-based imaging technique developed at the Institute predicts the response of ovarian cancer tumours to treatment, and rapidly reveals how well treatment is working, in patient-derived cell models.
Find out more -
Isabel Esain Garcia awarded PhD Thesis Prize
3rd December 2024
The Prize is awarded annually to a student who has undertaken an outstanding research project to the highest standards during the course of their PhD study at the Cancer Research UK Cambridge Institute.
Find out more -
World first trial to revolutionise treatment of brain cancer
23rd October 2024
A pioneering research study will trial multiple new treatments for people in the UK living with glioblastoma, an aggressive form of brain cancer.
Find out more